Kagan Ron M, Rogers Amy A, Borillo Gwynngelle A, Clarke Nigel J, Marlowe Elizabeth M
Quest Diagnostics Infectious Disease, San Juan Capistrano, California, USA.
Quest Diagnostics Nichols Institute, San Juan Capistrano, California, USA.
Open Forum Infect Dis. 2021 Jan 28;8(4):ofab039. doi: 10.1093/ofid/ofab039. eCollection 2021 Apr.
The use of a remote specimen collection strategy employing a kit designed for unobserved self-collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription polymerase chain reaction (RT-PCR) can decrease the use of personal protective equipment (PPE) and exposure risk. To assess the impact of unobserved specimen self-collection on test performance, we examined results from a SARS-CoV-2 qualitative RT-PCR test for self-collected specimens from participants in a return-to-work screening program and assessed the impact of a pooled testing strategy in this cohort.
Self-collected anterior nasal swabs from employee return-to-work programs were tested using the Quest Diagnostics Emergency Use Authorization SARS-CoV-2 RT-PCR. The cycle threshold (Ct) values for the N1 and N3 N-gene targets and a human RNase P (RP) gene control target were tabulated. For comparison, we utilized Ct values from a cohort of health care provider-collected specimens from patients with and without coronavirus disease 2019 symptoms.
Among 47923 participants, 1.8% were positive. RP failed to amplify for 13/115435 (0.011%) specimens. The median (interquartile range) Cts were 32.7 (25.0-35.7) for N1 and 31.3 (23.8-34.2) for N3. Median Ct values in the self-collected cohort were significantly higher than those of symptomatic but not asymptomatic patients. Based on Ct values, pooled testing with 4 specimens would have yielded inconclusive results in 67/1268 (5.2%) specimens but only a single false-negative result.
Unobserved self-collection of nasal swabs provides adequate sampling for SARS-CoV-2 RT-PCR testing. These findings alleviate concerns of increased false negatives in this context. Specimen pooling could be used for this population, as the likelihood of false-negative results is very low when using a sensitive, dual-target methodology.
采用专为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)逆转录聚合酶链反应(RT-PCR)的无人监督自我采集试剂盒的远程样本采集策略,可减少个人防护装备(PPE)的使用和暴露风险。为评估无人监督的样本自我采集对检测性能的影响,我们检查了一项复工筛查计划参与者自我采集样本的SARS-CoV-2定性RT-PCR检测结果,并评估了该队列中混合检测策略的影响。
使用奎斯特诊断公司的紧急使用授权SARS-CoV-2 RT-PCR检测员工复工计划中自我采集的前鼻拭子。列出N1和N3 N基因靶点以及人类核糖核酸酶P(RP)基因对照靶点的循环阈值(Ct)值。为作比较,我们利用了一组医护人员采集的有或无2019冠状病毒病症状患者样本的Ct值。
在47923名参与者中,1.8%呈阳性。13/115435(0.011%)的样本中RP未能扩增。N1的中位数(四分位间距)Ct值为32.7(25.0 - 35.7),N3为31.3(23.8 - 34.2)。自我采集队列中的Ct中位数显著高于有症状但无症状患者的Ct中位数。基于Ct值,4个样本的混合检测在67/1268(5.2%)的样本中会得出不确定结果,但只有1例假阴性结果。
无人监督的鼻拭子自我采集为SARS-CoV-2 RT-PCR检测提供了足够的样本。这些发现减轻了在这种情况下对假阴性增加的担忧。样本混合可用于该人群,因为使用灵敏的双靶点方法时假阴性结果的可能性非常低。